Items where authors include "Critchlow, S."

Article

Critchlow, S. orcid.org/0000-0001-6862-765X, Bullement, A. orcid.org/0000-0001-7091-0972, Crabb, S. orcid.org/0000-0003-3521-9064 et al. (9 more authors) (2023) Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future Oncology. ISSN 1479-6694

Proceedings Paper

Bullement, A., Critchlow, S., Stevenson, M.D. orcid.org/0000-0002-3099-9877 et al. (2 more authors) (2022) HTA225 A review of external evidence used to support survival extrapolation in assessments of cancer drugs by the National Institute for Health and Care Excellence (NICE). In: Value in Health. ISPOR Europe 2022, 06-09 Nov 2022, Vienna, Austria. Elsevier BV , S340-S340.

Critchlow, S., Xiao, Y., Crabb, S. et al. (9 more authors) (2022) POSC4 Modeling health-related outcomes with avelumab as a first-line maintenance treatment following chemotherapy vs. best supportive care (BSC) for patients with locally advanced or metastatic urothelial cancer in the UK. In: Value in Health. Virtual ISPOR Europe 2021, 30 Nov - 03 Dec 2021, Virtual conference. Elsevier BV , S32-S33.

Bullement, A. orcid.org/0000-0001-7091-0972 and Critchlow, S. (2016) PRM119 - An exploration of techniques for addressing uncertainty in survival estimates used within partitioned-survival models. In: Value in Health. ISPOR 19th Annual European Congress, 29 Oct - 02 Nov 2016, Vienna, Austria. Elsevier , A378-A379.